New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For OPXA;MKGAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
08:36 EDTOPXACryoport to support Opexa Therapeutics' T-cell immunotherapy programs
Cryoport's (CYRX) validated cryogenic logistics solution will support future clinical trials for Opexa Therapeutics' (OPXA) lead personalized T-cell immunotherapy programs for Multiple Sclerosis and Neuromyelitis Optica. Cryoport's global distribution network will provide the necessary cryogenic logistics support between Opexa and its clinical sites.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use